0BO vs C1S: Side-by-Side Comparison
Compare Jiangsu Hengrui Pharmaceuticals Co.,Ltd (0BO) and China Shineway Pharmaceutical Group Limited (C1S) side by side: market cap EUR 38.83B vs EUR 608.10M, P/E 36.6 vs 5.0. Financials, growth and model signals on Bullrun.
| Metric | 0BO | C1S |
|---|---|---|
| Company | Jiangsu Hengrui Pharmaceuticals Co.,Ltd | China Shineway Pharmaceutical Group Limited |
| Country / Exchange | China · F | China · F |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic | Drug Manufacturers - Specialty & Generic |
| Market cap | EUR 38.83B | EUR 608.10M |
| P/E ratio | 36.6 | 5.0 |
| Dividend yield | 0.43% | 8.12% |
| Valuation model | 24.2% overvalued | — |
| Revenue (latest FY) | — | EUR 3.14B |
| Revenue growth YoY | — | -17.0% |
| Net income | — | EUR 949.95M |
| Gross margin | — | 72.3% |
| Diluted EPS | — | 1.26 |